11 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 11 of 11 clinical reviews.
A guide covering how older adults on Repatha (evolocumab) can safely maintain physical activity, community programs, and daily routines, with dosing, monitoring, and exercise interaction data.
A comprehensive clinical review of how evolocumab (Repatha) affects growth, puberty, hormones, bone, and neurodevelopment in adolescents ages 12 to 17, with trial data, dosing guidance, and monitoring protocols.
A clinical review of off-label evolocumab (Repatha) use in adolescents ages 12 to 17, covering trial data, dosing, safety, and guideline recommendations for pediatric familial hypercholesterolemia.
A guide to managing Repatha (evolocumab) therapy in adolescents ages 12 to 17, covering school accommodations, injection timing, sports participation, and activity safety.
A clinical deep-dive into how evolocumab (Repatha) performs in patients aged 65 and older, covering LDL reduction, cardiovascular outcomes, safety signals, dosing considerations, and what geriatric physiology means for long-term PCSK9 inhibitor therapy.
A guide to evolocumab (Repatha) use in geriatric patients aged 65+, covering trial evidence, dosing, safety, drug interactions, and practical decision-making for older adults with elevated LDL-C.
A guide to evolocumab (Repatha) use in pediatric patients under age 12, covering developmental safety data, FDA approval status, cholesterol biology in children, and clinical trial evidence.
A guide for parents and school nurses on managing evolocumab (Repatha) therapy in children under 12, covering injection schedules, PE participation, injection site care, and communication with school staff.
A clinical guide for geriatric patients and providers managing evolocumab (Repatha) therapy at age 65+, covering dosing, safety, LDL targets, Medicare coverage, and care-transition checkpoints.
Complete caregiver guide for administering Repatha (evolocumab) to adults aged 65 and older: injection technique, storage, missed doses, monitoring, and when to call the prescriber.
Step-by-step caregiver guidance for administering Repatha (evolocumab) to children under 12, including approved indications, dosing, injection technique, storage, and safety monitoring.